morning well joining and financial to as [indiscernible] quarter provide our Baxter's everyone. morning, financial outlook details performance good year on and for this XXXX. commentary as additional some to the Heather, fourth Thanks, call full on XXXX
pleased we As results the very year. ended we how Brent and mentioned, quarter are with fourth our
Our to constant $X.XX a results and on bottom on called prior sales lines, the billion, quarter sales increased solid guidance our reported XXXX favorably X% basis, came and sales operations top decline from to in operational better-than-expected by performance. single low of a continuing on both which global in driven currency X% digits. Fourth ahead and for our compared previous guidance, basis and of
most Our sales divisions. and reflected of performance across quarter broad-based product in was our positive the
As approximately $XXX impacted Hurricane or sales during XXX our the fourth million by approximately expected, quarter, Helene negatively basis that points.
recovery Although previously $XXX company's less magnitude the efforts. approximately is the million, overall given anticipated than swift the
operations sales over Hurricane the both full for currency negatively $XX.X For the from increasing by reported basis full Helene on XXX basis. at growth billion, impacted the points. constant reported year, year and Baxter X% considered just
adjusted solid earnings $X.XX, the operations our of from results favorable bottom share driven $X.XX ahead and were by half-life performance. guidance of to quarter and per $X.XX operational per share, continuing prior fourth line, in the came On
In which to operations foreign primarily adjusted to share per On results. on a from addition, earnings offset our exchange. favorable declined from of came year-over-year impact our Hurricane tax conation, the in impact continuing negative basis, the quarter, in negative Helene a XX% rate our due
underlying operational adjusted rate. tax nonoperational lower share performance solid expense from reflecting operations and and continuing from share including full interest increased $X.XX a prior the year, the benefit For over and earnings year, totaled XX% per items, per
Now Sales Products Medical results our billion, our the to through and reflect constant X% MPT regarding expectations. in Therapies, Commentary and for or sales $X.X our reportable will segments. growth favorable in increasing I'll currency segment in quarter were growth at walk coming rates.
year the ahead X%. sales X% the infusion in totaled Full approximately for approximately prior guidance X% from sales Technologies and Adjusting therapies advancing growth William decreased totaled and fourth sales $X.X the of quarter would and X% of been the have XXXX Within X% of billion our full $X.X division growth. NPT, to X% and billion, for impact year. quarter
as of site our continues quarter advanced the Nova reflecting build our rollout digits for new growth in build benefited our pub the systems in momentum portfolio. customers. alternate platform quarter as double both in strength IQ out the significant existing from Sales Nutrition portfolio U.S. we to the orders to and sales globally in coming U.S. with continue infusion the from
than and was and for for [indiscernible] the declined anticipated, to $XXX demand sales as MPT's Results the X% in in QX outperformance. the quarter positive Advanced operating Helene. globally. of in pricing coming Surgery globe. Hurricane the our portfolio quarter quarter adjusted due to solid expected better and the IV reflected totaled the Solutions impact Finally, million sealant XX.X%, grew of due sales margin of across
year the totaled quarter $XXX expectations were million billion primarily sales Full and reflecting [indiscernible], in Margins X%. the and Healthcare of totaled In in the declined line X%. decreasing XXXX or declined impact sales with year-over-year, $X hurricane. HST,
by Solutions, HFC growth quarter or business. upgrades Performance delivered a globally. due the for our in well the in Systems Within quarter were and Connectivity our which in for existing continued sales X% Care growth strong our segment, million, competitive driven again PSS was product division the Search $XXX and lines U.S. CCS ICU in in both or CCS customers. the Patient for advancing as Support benefit X% and from once reflected as momentum wins men's to
rose CCS the Total XX% U.S. and year. the quarter increased full capital for X% in orders for
prior $XXX contributed We to positively are quarter was by period. Performance with XX% in positive year for Care we a performance softness the course also and quarter division over certain well and strong in in saw difficult a commentary of backlog impacted million the the and growth the over this build year. U.S., of collectively outside the exits reductions, sales market in the China Results course reflected the which prior in by the impact weaker the of momentum both backlog with and quarter in year this offset supply France year, comparison quarter. Consistent current approximately [indiscernible] which $XX the million partially as of the to the sales Frontline sales declined period, exiting as X%. constraints, was were reflecting XXXX. funnel impacted a leader to by sales healthy in
XXXX. first the fourth impacted products that the largely expect for the to supply of most in resolved We constraints quarter be quarter
primary beyond. believe this of FLC over market adjusted division of products year operating launch performance margin the positive benefit fourth continuing will care the to sequential and sequentially, are that HSE half increased this the to XXXX central of expected the improvements. performance also in quarter second of contribute margins for XX.X% trend well course in that of XXXX as We for the as stabilization from in
Margins primarily investments. declined year-over-year, higher reflecting
an reflected quarter X%. Moving sales came anticipated advancing quarter growth $XXX of $X.X was favorable sales year XXXX injectable and increasing expectations our on by grew an in mid-teens to timing portfolio, X%. the from specialty million, Performance orders. the impacted totaled and the at Full $XXX in third in Sales in our were quarter rebound Pharmaceutical anesthesia million, the injectables segment. quarter, which to with billion, of Fourth X%. some
implemented. driven benefit of premixed U.S. Growth as been new strong targeted and have the sales from was that and well initiatives by continued products the marketing demand for rollout products as
in which lower of anesthesia. expected, slightly performance drug the overall quarter. As and continued for Within inhaled demand of for growth sales services mid-single strong tempered injectables resulted the anesthesia, for X% digits, compounding, declined
reflecting margins XX.X% adjusted basis margins quarter points increased and focused the The upcoming to expenses Adjusted the XXX MSA expanding primarily from for the not improved increasing business margins operating entered business, totaled for impact the services into and include launches. the products facilities XXXX. in and Pharmaceutical executing support initiatives following the improvements, decreased and margin year, the stabilizing sales, the were operating BPS were new basis to XXX provided to chain. on manufacturing in team prior those pharmaceuticals points sales remains Other and compared operating cost driving and the certain our mix, sales sequentially. supply million compounding directly sales and quarter year $XX improvement of $XX our integrated full segments which represent allocated million to anesthesia through
Care have Kidney P&L the forward. as due operations last on continuing rest segment discontinued moving that the our regarding to change comments to that of the reported wanted not convey results, to in moving in business would sale quarter, now operations, corporate reported some with results Kidney costs. of corporate Care costs the Care mentioned make been previously business I Before going to unallocated are the I Kidney allocated to the
offset through the income undertaking. XXXX As services we TSAs, previously of these to be the initiatives or Vantiv we company commented, portion as under in agreements, in containment to transition a cost already plan as process from of expenses well the large is received
Our goal loss reflecting XX.X%, fully gross offset sequential XXXX. by basis in a operations adjusted expectations to stranded continuing the impact remains improvement income costs TSA of of points. of was of to XX margin and Fourth from the favorable coming quarter and end the
of by basis, plants supply manufacturing XX within primarily higher year-over-year slightly growth points adjusted spend to impact declined as of manufacturing the a the product by [indiscernible] Hurricane PS. well support following the gross agreement as On Helene, basis of margins sale impact the driven
select gross in margin mix chain the for our programs initiatives to from margin continuing totaled in margin supply printing network quarter as as Adjusted ongoing our and favorable operations from contributors Positive integrated the improvement year well were benefits within XX.X%. product markets.
incurred an support million prior basis our SG&A adjusted growth the This year of phasing costs. launches. increase from as stranded approximately continue represented stock items quarter, and of not adjusted lower from benefits claims quarter percent sales, across million totaled from $XX points innovation objectives our X.X% optimization expenses as of by sales, to increased investments discrete represented million or an the billion program full XXXX offset select totaled portfolio were expenses of repeat, to period, points product expenses. and and with continued XXX operations due contingent and basis our to XXXX higher products compensation SG&A $X.XX a new during These percentage care the to patients a year period adjusted select continuing are as tax Adjusted in of make year quarter XX.X% XX as of XX% sales. R&D R&D increase Full operations $XXX $XXX totaled or Fourth medical totaled to we and sales. from investments compared advancing the associated of the reflects and across expected bringing our increase in to a including million employee of percentage fees year also prior health X.X% included that high-cost $XXX spending new
[indiscernible] year margin increase compared an prior the adjusted income. interest as to reflecting factors from $XX from from prior unfavorable foreign margins points, $X.X continuing in impact basis operations driven period, was sales. operating decreased lower continuing year, versus Net approximately operating million expense well totaled year the or XXXX, million operations the $XX the quarter, XX.X% as operations exchange. interest the continued by discussed of from of I Full adjusted just XXX billion
For $XXX the $XX million interest the the in Adjusted income in nonoperating period. of year debt expense decreasing income $X $XX prior of and year, million million, net the quarter full repayment other to totaled compared reflecting benefit totaled our million initiatives.
year, optimize tax operations income undertaken rates For our fourth was rate. initiatives XX.X%, rate to have continue tax other and that the adjusted global year both of the the we full reflect nonoperating quarter benefit full tax
were interest performance continuing earnings approximately $X.XX positive launches for $X.XX these per negative XX% and commercial by we Helene, estimate versus prior And as new operations approximately pricing. and the the share. year. contributions product impacted by an Hurricane Positive our were adjusted previously expense and to which quarter per In from earnings quarter, drivers improved and the mentioned, of unfavorable impact the $X.XX offset decreased included share results foreign impact per from of exchange from share
continuing totaled year the year an per adjusted prior $X.XX of XXXX Full from share earnings share, increase period. XX% to operations compared per as
underpinning discussing by for the remarks year including operations. discontinued full assumptions of my conclude guidance. guidance quarter of All the the the of Care XXXX, me Let and XXXX our excludes impact key outlook first provided Kidney some
This basis growth XXXX, rates revenues basis. X% million of impact total approximately a Vantive For X% anticipated reported on to guidance full Baxter exchange $XXX XXX on an negative current as year expects from MSA from of point includes as based sales foreign approximate well
points segment launch, guidance sales business MPT, year we continued our increase in impact underlying approximately planned impact other to For the LVP on as This exit basis Operationally, Baxter Operational Mogam X%. expects sales momentum driving to profitable exchange, reportable the pricing in by for to from from China foreign is of exiting business grow in MSA X% solutions negative of to The the approximately the revenues the company guidance IP the driven IV follows: and X%, sales growth. excludes of from solutions is focus China the positive as and continues growth. Baxter. to XX benefit U.S. full by expect
estimated expected approximately guidance points. market our exiting impact Sales which in ID across solutions the both and X%, expected in XXX increase balanced impact is to by China, to growth CCS be sales basis to the FLC. of and segment HFC This are is excludes
We drug X% by mid-single-digit both expect Specialty and growth to approximately pharmaceuticals to and compounding. X% Injectables driven in increase
our turn line I'll to for P&L items. outlook other Now
from total approximately margin continuing of XX.X% operating adjusted includes approximately TSA and income year full expect we million. shared, previously As operations to $XXX
nonoperating net expenses, and expense include other our expect expense. We interest income and which
full of we million anticipate year between XX.X%. $XXX approximately tax total million. basis, continued So to a operations rate On $XXX a
XXXX. for on share these $X.XX does all the an to share continuing outlook approximately I'd from of on a earnings million diluted negative for of anticipate to factors, diluted operations our on quick based $X.XX now of current estimated not exchange adjusted share which includes per regarding year, year A rates. full XX per Based impact to like any shares our share. average outlook couple make repurchases. foreign This we $X.XX expect contemplate basis, We other comments count approximately
does in potential that contemplated China, the tariffs from Canada, given reflect slight First, fluidity that and I'd includes potential tariffs from any for situation impact possible exemptions. and for delays further but a point our enacted the Mexico and not implementation out are guidance current of impact
to [indiscernible] discontinued care not the unallocated with convey XXXX, Second, allocated operations been in has were previously did kidney in reported costs. that presentation corporate
Starting expect and basis. of segments, in XXXX, growth the a an XXXX, operational allocated to in with approximately reported X% costs operational of be these Specifics quarter X on will approximately related basis. TSA sales we to continued income. X% the first on X% along
foreign quarter, by million. XXX the exchange basis points are expected impact revenues negatively line $XX expected the approximately than first and is more total MSA For to top to
share The we Vantive as $X.XX China of earnings continuing XX XX able we is points in basis the compared XX per December ID been of Solutions a on by quarter. to expect This On share. approximately that line impact to sale share quarter closing January impact earnings in per negatively growth on and approximately guidance per date. the the first by which top basis, had close $X.XX to reflects $X.XX of closing the exit the expected impacted operations on adjusted to
we now call for Q&A. the open can up With that,
